Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) in hypogonadotropic hypogonadism with persistent azoospermia after hormonal therapy
- PMID: 15202738
- PMCID: PMC3455403
- DOI: 10.1023/b:jarg.0000027021.66435.02
Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) in hypogonadotropic hypogonadism with persistent azoospermia after hormonal therapy
Abstract
Purpose: We aimed to retrieve testicular sperm to be employed on intracytoplasmic sperm injection (ICSI) cycles on a male affected of hypogonadotropic hypogonadism (HH) that remained azoospermic after long-time hormonal treatment.
Methods: Design. We initially performed hormonal therapy using gonadotropins to achieve spermatogenesis. After several semen analyses, we weighed the possibility of looking for testicular spermatozoa for ICSI. Setting. A private university-affiliated setting. Patient. A 30-years-old man diagnosed 10 years ago to suffer from idiopathic, prepubertal HH. Interventions. Gonadotrophin treatment was initiated with hCG and follicle stimulating hormone (FSH). Testicular sperm extraction was carried out when repeated spermiograms were negative. Motile testicular spermatozoa were cryopreserved and were subsequently employed for ICSI. Multiple follicular development was stimulated with gonadotropins after a downregulation with gonadotropin-releasing hormone (GnRH) antagonists in the woman. Main Outcome Measures. Seminal analyses were performed after 3, 6, and 12 months of treatment and serum FSH, luteinizing hormone (LH) and testosterone levels were also measured.
Results: Seminal analysis showed always azoospermia. Serum FSH was 2.9 mIU/mL, serum LH >1 mIU/mL and serum testosterone 7.9 ng/mL (12 months after treatment). Nine oocytes were collected by ultrasound-guided transvaginal route and eight of them were microinjected with motile, frozen-thawed testicular spermatozoa. Four oocytes were fertilized. Three embryos were transferred without pregnancy.
Conclusions: The case report here presented shows that the currently available assisted reproduction techniques may be of value in patients with HH not responding to conventional hormonal treatments.
Similar articles
-
ICSI using testicular sperm in male hypogonadotrophic hypogonadism unresponsive to gonadotrophin therapy.Hum Reprod. 2004 Jul;19(7):1558-61. doi: 10.1093/humrep/deh243. Epub 2004 May 13. Hum Reprod. 2004. PMID: 15142993 Clinical Trial.
-
Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7. BJU Int. 2013. PMID: 22958644
-
Pregnancies achieved by testicular sperm recovery in male hypogonadotrophic hypogonadism with persistent azoospermia.Reprod Biomed Online. 2009 Apr;18(4):455-9. doi: 10.1016/s1472-6483(10)60119-8. Reprod Biomed Online. 2009. PMID: 19400984
-
Pregnancy after intracytoplasmic sperm injection following extended sperm preparation and hormone therapy in an azoospermic man with maturation arrest and microlithiasis: a case report and literature review.Andrologia. 2017 Jun;49(5). doi: 10.1111/and.12665. Epub 2016 Jul 29. Andrologia. 2017. PMID: 27469438 Review.
-
Impact on using cryopreservation of testicular or epididymal sperm upon intracytoplasmic sperm injection outcome in men with obstructive azoospermia: a systematic review and meta-analysis.J Assist Reprod Genet. 2020 Nov;37(11):2643-2651. doi: 10.1007/s10815-020-01940-1. Epub 2020 Sep 15. J Assist Reprod Genet. 2020. PMID: 32935172 Free PMC article.
Cited by
-
Reproductive outcomes of microdissection testicular sperm extraction in hypogonadotropic hypogonadal azoospermic men after gonadotropin therapy.J Assist Reprod Genet. 2021 Oct;38(10):2601-2608. doi: 10.1007/s10815-021-02211-3. Epub 2021 May 12. J Assist Reprod Genet. 2021. PMID: 33982169 Free PMC article.
-
Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk.J Assist Reprod Genet. 2022 Oct;39(10):2275-2285. doi: 10.1007/s10815-022-02595-w. Epub 2022 Aug 16. J Assist Reprod Genet. 2022. PMID: 35972585 Free PMC article.
-
Comparison of outcomes between pulsatile gonadotropin releasing hormone and combined gonadotropin therapy of spermatogenesis in patients with congenital hypogonadotropic hypogonadism.Reprod Biol Endocrinol. 2025 Mar 21;23(1):46. doi: 10.1186/s12958-025-01370-7. Reprod Biol Endocrinol. 2025. PMID: 40119359 Free PMC article.
References
-
- Gilbaugh JH, III, Lipshultz LI. Nonsurgical treatment of male infertility. Urol Clin North Am. 1994;21:531–548. - PubMed
-
- Hakim L, Oates RD. Nonsurgical treatment of male infertility: Specific therapy. In: Lipshulz LI, Howards SS, editors. Infertility in the Male. St Louis, MO: Mosby; 1997. pp. 395–409.
-
- European Metrodin HP Study Group: Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil Steril 1998;70:256-262 - PubMed
-
- Buchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as affective treatment for men with hypogonadotropic hypogonadism: A review of 42 cases. Eur J Endocrinol. 1998;139:298–303. - PubMed
-
- Finkel DM, Phillips JL, Zinder PJ. Stimulation of spermatogenesis by gonadotropins in men with hipogonadotropic hipogonadism. N Engl J Med. 1985;313:651–653. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources